As the U.S. government retreats from public health projects in Africa, it leaves a diplomatic hole that China can fill ...
HOOKIPA Pharma (HOOK) announced that enrollment is complete in the Phase 1b clinical trial evaluating HB-500 for the treatment of HIV, with 30 participants enrolled across five sites in the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback